Product Information
Registration Status: ActiveSIN11521P
FANHDI FOR INJECTION 250 IU/VIAL is approved to be sold in Singapore with effective from 2001-05-17. It is marketed by GRIFOLS ASIA PACIFIC PTE LTD, with the registration number of SIN11521P.
This product contains Antihemophilic Factor Viii (Human) 250 iu/vial in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by INSTITUTO GRIFOLS in UNITED STATES, and S.A. in SPAIN.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.